MAM
GSK icon

Mystic Asset Management’s GSK GSK Stock Holding History

Mystic Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,869
Closed -$428K – 147
2022
Q2 		$428K Hold
7,869
– – 0.26% 104
2022
Q1 		$428K Hold
7,869
– – 0.23% 117
2021
Q4 		$433K Buy
+7,869
New +$409K 0.2% 116

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mystic Asset Management's GSK Position: Q3 2022 in Review

Mystic Asset Management sold out of GSK (GSK) in Q3 2022, closing a stake of 7,869 shares — an estimated $428K sold.

Mystic Asset Management first reported a position in GSK in Q4 2021 and held it in 3 quarters. The position peaked at $433K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Mystic Asset Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Mystic Asset Management sold 7,869 GSK shares in Q3 2022, an estimated $428K.
  • Mystic Asset Management first reported a position in GSK in Q4 2021 and held it in 3 quarters.
  • Mystic Asset Management's GSK position peaked at $433K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Mystic Asset Management's 13F filing for Q3 2022, filed 18 Oct 2022.